SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-001291
Filing Date
2022-01-05
Accepted
2022-01-05 08:45:17
Documents
14
Period of Report
2022-01-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221664d1_8k.htm   iXBRL 8-K 27048
2 EXHIBIT 99.1 tm221664d1_ex99-1.htm EX-99.1 21981
6 GRAPHIC tm221664d1_ex99-1img001.jpg GRAPHIC 3050
  Complete submission text file 0001104659-22-001291.txt   234354

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA albo-20220103.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20220103_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20220103_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm221664d1_8k_htm.xml XML 3581
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 22509523
SIC: 2834 Pharmaceutical Preparations